Congress and President Donald Trump are starting to wrestle with health policy issues, and health is already a key debate point in the early run-up to the 2020 Democratic presidential primaries. Might any major health policy legislation be passed and signed this year? Joanne Kenen of Politico, Anna Edney of Bloomberg News and Kimberly Leonard of The Washington Examiner, along with special guest Tom Miller of the American Enterprise Institute, join KHN’s Julie Rovner to discuss these issues and take questions from a live studio audience.
Category: Trump Administration
Podcast: KHN’s ‘What The Health?’ ‘Medicare-For-All’? More? Some?
“Medicare-for-all” has become the rallying cry for Democrats in the new Congress. But there is a long list of other ways to increase insurance coverage. Meanwhile, the Trump administration continues to chip away at the Medicaid program for the poor, and new rules could mean higher costs for individual health insurance in 2020. Alice Ollstein of Politico, Stephanie Armour of The Wall Street Journal and Paige Winfield Cunningham of The Washington Post join KHN’s Julie Rovner to discuss these issues and, for “extra credit,” provide their favorite health policy stories of the week.
Podcast: KHN’s ‘What The Health?’ Drug Prices Are Rising Again. Is Someone Going To Do Something About It?
As drugmakers hike prices, interest to rein them in grows on Capitol Hill. Next week marks the anniversary of Roe v. Wade, the Supreme Court’s abortion decision, and both the House, whose leaders back abortion rights, and the Senate, controlled by abortion foes, are holding statement votes. And the government shutdown is still affecting health programs. Joanne Kenen of Politico, Margot Sanger-Katz of The New York Times and Alice Ollstein of Politico join KHN’s Julie Rovner to discuss these issues.
Providers Walk ‘Fine Line’ Between Informing And Scaring Immigrant Patients
Some doctors and clinics are proactively informing patients about a proposed policy that could jeopardize the legal status of immigrants who use public benefit programs such as Medicaid. Others argue that because this “public charge” proposal isn’t final — and may never be adopted — disseminating too much information could create unnecessary alarm and cause some patients to drop benefits.